glp-1 lawsuit lawyer fee structures atlanta Lawsuits claiming Ozempic, other GLP-1s led to blindness become second mass litigation over the drugs Ozempic Blindness Lawsuit [2026 Guide]

AbbVie, which paid $350 million to license a long-acting amylin analog from the firm Gubra, also recently announced Phase 1 data

In this context, "claims evaluated" refers to an effort to clarify how the product is described across its marketing materials and how those descriptions align with ingredient-level research and general scientific understanding

These data should be interpreted as an early signal that warrants further investigation, a researcher involved in the study told Live Science

After around four months of dose titration, most protocols aim for a semaglutide maintenance dose for weight loss of 2.4 mg per week

2b and Supplementary Fig

In recent coordinated actions, a coalition of 38 State AGs raised concerns regarding: products containing unknown contaminants or incorrect dosages